SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0000078003-21-000099
Filing Date
2021-09-17
Accepted
2021-09-17 16:27:08
Documents
2
Group Members
PF EQUITY HOLDINGS 1 B.V.

Document Format Files

Seq Description Document Type Size
1 SC 13D/A CEREVEL THERAPEUTICS HOLDINGS sch13d_axcere.htm SC 13D/A 121790
2 EX-99.1 JOINT FILING AGREEMENT exh99c.htm EX-99.1 4475
  Complete submission text file 0000078003-21-000099.txt   128046
Mailing Address 235 E 42ND ST NEW YORK NY 10017
Business Address 235 E 42ND ST NEW YORK NY 10017 2125732323
PFIZER INC (Filed by) CIK: 0000078003 (see all company filings)

IRS No.: 135315170 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A
SIC: 2834 Pharmaceutical Preparations

Mailing Address 222 JACOBS STREET SUITE 200 CAMBRIDGE MA 02141
Business Address 222 JACOBS STREET SUITE 200 CAMBRIDGE MA 02141 844-304-2048
Cerevel Therapeutics Holdings, Inc. (Subject) CIK: 0001805387 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-91809 | Film No.: 211260730
SIC: 2834 Pharmaceutical Preparations